Manage your personalised Watchlist.Set up an online Virtual Portfolio.Participate in Share Chat.See more trades and director dealings.Play the Fantasy Share Trading Game.
Register for FREE Now
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.
Oakleaf72
Posted in: SNG
Posts: 1,986
Price: 210.00
No Opinion
Wyndrum, just compare the team now to then. I think you are spot on.
Price: 208.20
I agree Big but I also believe that all of this will be in hand, it's major condition of the Activ trial too.
Price: 204.60
The last patient recruitment RNS came out 28th May last year. Add 35 days for unblinding and that gets you to 2nd July. P2 readout RNS was 20th July.
Price: 205.00
The 19 percent short is still in play
He also said that RM has more detail on when this drug will be available.
Price: 207.00
If only Fruits
Price: 203.80
Designed to divert attention. Ignore and Don't reply
Price: 204.20
Just look at the SP lol
And they are back. Don't be ridiculous Andrew. This drug will change how we treat respiratory illnesses in future, CGo and do some home work
Price: 200.60
Best post of the day Kaeren.
Price: 201.40
Go away Ndn, you peddle nonsense.
Ndn, the only de-ramper left
Price: 194.80
Nicely put Fruits
Price: 194.10
Ndn The board has been very civil and positive since yesterday, please don't spoil it.
Price: 196.00
Yep me too.
Price: 190.00
Thanks Mat. Lovely bit of fanfare to from Sir Stephen with RM to follow. Expecting a very blue day today.
Price: 190.50
Also agreed. Lots of very selfish behaviour evident.
Price: 192.10
More transmission = more variants. It's only a matter of time.
Agreed Bruce. Seems that way
Yep, a friend of mine has a 12 year old Son who is very sick. Worrying for us parents. She too has it and double jabbed but feeling awful.https://www.dailyrecord.co.uk/news/uk-world-news/parents-warned-unusual-symptom-affecting-25648708
Login failed